Harald Schwalbe

Title: The Innovations of Harald Schwalbe

Introduction

Harald Schwalbe is a notable inventor based in Frankfurt-am-Main, Germany. He has made significant contributions to the field of medical research, particularly in the development of therapies targeting receptor tyrosine kinases. His work is crucial in addressing various diseases, including cancer and autoimmune disorders.

Latest Patents

Harald Schwalbe holds a patent for "Receptor tyrosine kinase inhibitors for treatment of protein kinase modulation-responsive disease or disorder." This patent focuses on Ephrin type receptor tyrosine kinase inhibitors, also known as Eph tyrosine kinase receptor inhibitors. These inhibitors are particularly useful for treating certain cancers, inflammatory diseases, autoimmune diseases, and degenerative diseases characterized by abnormal activity or expression of the Eph receptor tyrosine kinase. He has 1 patent to his name.

Career Highlights

Schwalbe's career is marked by his dedication to advancing medical science through innovative research. He works for the United States of America, as represented by the Secretary, Department of Health and Human Services. His research has the potential to transform treatment options for patients suffering from various serious health conditions.

Collaborations

Some of his notable coworkers include Giovanna Tosato and Michael J DiPrima. Their collaborative efforts contribute to the advancement of research in the field of receptor tyrosine kinases.

Conclusion

Harald Schwalbe's work exemplifies the impact of innovation in medical research. His contributions to receptor tyrosine kinase inhibitors are paving the way for new treatment options for patients with challenging diseases.